Standardized Assays for Profiling Antibody Candidates against SARS-CoV2
$1,555,327Y01FY2020AINIH
National Institute Of Allergy And Infectious Diseases
Investigators
Abstract
The objective of this agreement is to provide in vivo efficacy testing of neutralizing antibody products in an animal model of SARS-CoV-2 infection.
View original record on NIH RePORTER →